Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

ActiGraph Announces Official Partnership with Chinese Reseller, B&E Teksystems


PENSACOLA, Fla., May 25, 2021 /PRNewswire-PRWeb/ -- ActiGraph, a leading global provider of medical-grade wearable technology solutions for pharmaceutical and academic research, is pleased to announce its new, non-exclusive partnership with B&E Teksystems. Headquartered in Beijing, B&E Teksystems is a supplier of life science equipment and technical services for Mainland China. They are ActiGraph's first official reseller in China, a region that is experiencing rapid growth in clinical research opportunities.

"B&E Teksystems has been our top producer in China for years, and we are looking forward to continuing our great relationship," says Milan Brunet-Sabastia, ActiGraph Channel Sales Manager, EMEA. "The company is already very active in academic research, and we expect them to provide significant support to clinical trials as well."

This partnership has been made successful as a result of B&E Teksystems' local business expertise and customized service offerings combined with ActiGraph's high quality, science-backed technology.

"B&E Teksystems provides clients with timely, localized services, such as technology implementation, training, and after-sales support. We help customers better understand the applications for ActiGraph equipment," says Chen Yuanchun, B&E Teksystems Executive Director and Manager. "Although there are a lot of wearable devices available, ActiGraph products rely on professional algorithms supported by scientific literature, making them favored by many researchers. This sets ActiGraph apart from other personal wearable devices. We are very happy to formalize our partnership with ActiGraph and look forward to expanding the market for their technology in China even more in the future."

About B&E Teksystems - Founded in 2010, B&E Teksystems specializes in importing and selling life science equipment and technical services. The company primarily focuses on medical research in the fields of physiology, pharmacology, toxicology and neuroscience. The team at B&E Teksystems is able to apply years of industry experience toward helping customers find solutions in these therapeutic areas. They pride themselves on high quality products and superior customer service. Learn more at bandetek.com

About ActiGraph - ActiGraph's mission is to bring life to digital data. Built on more than twenty years of remote data capture expertise, ActiGraph is the leading provider of medical-grade wearable motion sensors for the global scientific community. ActiGraph's FDA-cleared biosensors and flexible technology ecosystem deliver high quality, continuous digital data, providing valuable insights into the real world behaviors of clinical trial participants. Appearing in more than 17,000 published scientific papers to date, ActiGraph is the industry's most experienced, knowledgeable, and trusted wearable technology partner. Learn more at theactigraph.com

Media Contact

Genevieve Baley, ActiGraph, +1 (850) 332-7900, [email protected]

Twitter, Facebook

 

SOURCE ActiGraph


These press releases may also interest you

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...

16 mai 2024
TSX VENTURE COMPANIES BULLETIN V2024-1467 DECISIVE DIVIDEND CORPORATION ("DE")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  May 16, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per common share:...

16 mai 2024
CHICANE CAPITAL II CORP. (the "Corporation") is pleased to announce the filing of a final prospectus for its initial public offering. Access to the prospectus and any amendment thereto is provided in connection with the Corporation's initial public...



News published on and distributed by: